D‐dimer enhances risk‐targeted thromboprophylaxis in ambulatory patients with cancer
Background Thromboprophylaxis for ambulatory patients with cancer is effective, although
uncertainties remain on who should be targeted. Using D‐dimer values from individuals …
uncertainties remain on who should be targeted. Using D‐dimer values from individuals …
[HTML][HTML] Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer
Essentials• Venous thromboembolism (VTE) prevention strategies require effective risk
assessment models.• We sought to validate the Khorana Risk Score (KRS) in patients with …
assessment models.• We sought to validate the Khorana Risk Score (KRS) in patients with …
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States
AA Khorana, M Dalal, J Lin, GC Connolly - Cancer, 2013 - Wiley Online Library
BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
Venous thromboembolism and prophylaxis in cancer patients
S Paškauskas, J Pundzius, G Barauskas - Medicina, 2008 - mdpi.com
Venous thromboembolism is a serious complication in patients with cancer. The seriousness
of venous thromboembolism as a complication in cancer patients is becoming recognized as …
of venous thromboembolism as a complication in cancer patients is becoming recognized as …
Rivaroxaban thromboprophylaxis in high-risk ambulatory cancer patients receiving systemic therapy: results of a randomized clinical trial (CASSINI)
AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj… - 2018 - ashpublications.org
Background: Patients on systemic therapy for cancer are at varying risk for venous
thromboembolism (VTE) and its consequences. Thromboprophylaxis is recommended in …
thromboembolism (VTE) and its consequences. Thromboprophylaxis is recommended in …
Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy
NM Kuderer, CW Francis, E Culakova… - Journal of Clinical …, 2008 - ascopubs.org
9521 Background: Venous thromboembolism (VTE) is a common complication of cancer
occurring with increasing frequency. A recent meta-analysis of anticoagulation as a form of …
occurring with increasing frequency. A recent meta-analysis of anticoagulation as a form of …
[HTML][HTML] Risk assessment models of cancer-associated thrombosis-potentials and perspectives
Patients with cancer are at increased risk of venous thromboembolism (VTE). Risk
assessment models can help identifying high-risk populations that might benefit from …
assessment models can help identifying high-risk populations that might benefit from …
[HTML][HTML] Incidence of venous thromboembolism in patients with cancer–a cohort study using linked United Kingdom databases
BACKGROUND: Accurate population-based data are needed on the incidence of venous
thromboembolism (VTE) in patients with different cancers in order to inform guidelines on …
thromboembolism (VTE) in patients with different cancers in order to inform guidelines on …
[HTML][HTML] Clinical guide SEOM on venous thromboembolism in cancer patients
AJ Muñoz Martín, C Font Puig… - Clinical and …, 2014 - Springer
Venous thromboembolism (VTE) is a common event in cancer patients and one of the major
causes of cancer-associated mortality and a leading cause of morbidity. In recent years, the …
causes of cancer-associated mortality and a leading cause of morbidity. In recent years, the …
A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective …
PURPOSE Venous thromboembolism (VTE) is a leading cause of death among patients with
cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with …
cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with …